Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease

Introduction : Deep remission, defined as clinical remission with mucosal healing (MH), with anti-tumor necrosis factor (TNF)-α agents is a new target for therapy in Crohn’s disease (CD). Provided that the efficacy of infliximab (IFX) for induction of MH in CD has been demonstrated, there are much l...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Edyta Szymanska, Maciej Dadalski, Wieslawa Grajkowska, Sylwia Szymanska, Maciej Pronicki, Jaroslaw Kierkus
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Termedia Publishing House 2016-12-01
Reeks:Gastroenterology Review
Onderwerpen:
adalimumab
deep remission
mucosal healing
Crohn’s disease
Online toegang:https://www.termedia.pl/Adalimumab-for-endoscopic-and-histopathological-mucosal-healing-in-paediatric-patients-with-moderate-to-severe-Crohn-s-disease,41,28947,1,1.html
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items